AbbVie Inc. (NYSE: ABBV) shares are retreating Friday after trimming full-year adjusted EPS guidance below analyst targets.
AbbVie Inc.
(NYSE:ABBV) shares are retreating Friday as a modest reduction to full-year adjusted EPS guidance that pushed the midpoint beneath the analyst target proved enough to sour the market's mood.
Here's what you should know.
AbbVie shares are under pressure.
Why are ABBV shares declining?
AbbVie, Inc. (ABBV) is currently at $231.34, up $14.86 or 6.86%
AbbVie, Inc. (ABBV) is currently at $226.39, up $9.90 or 4.57%
AbbVie, Inc. (ABBV) is currently at $244.10, down $3.90 or 1.57%
Abbott Laboratories (NYSE:ABT) reported strong Q2 results, raising its full-year earnings outlook. Analysts have a positive…
AbbVie Declares Quarterly Dividend
Abbott (ABT) stock jumps 12% after beating Q2 2026 earnings and revenue estimates and raising its full-year profit outlook. Read…
